Skip to content

Neuroprotective Effects of Stingless Bee Honey (Trigona spp) Supplementation on Halting Vascular Mild Cognitive Impairment among Post-Stroke Patients

Exploring the Neuroprotective Effects of Stingless Bee Honey (Trigona spp) Supplementation on deferring Vascular Cognitive Impairment Among Post-Stroke Patients at Hospital Universiti Sains Malaysia

Status
Unknown
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230320003
Enrollment
90
Registered
2023-03-20
Start date
2021-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Mild Cognitive Impairment among Post-Stroke Patients Stroke, Vascular Mild Cognitive Impairment

Interventions

The stingless bee honey (SBH)-supplemented group will be supplemented with 20g of SBH daily for three months via oral administration.
Experimental Dietary Supplement
Stingless bee honey (Trigona spp)

Sponsors

Universiti Sains Malaysia
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Confirmed Acute Ischemic stroke patients based on clinical and radiological features (American Heart Association (AHA)/American Stroke Association (ASA) definition). 2. Age between 40-80 years old. 3. Hospitalized within 72 hours after the acute stroke. 4. A stroke patient with mild to severe VCI determined by Montreal Cognitive Assessment (MoCA) score (<26/30).

Exclusion criteria

Exclusion criteria: 1. History of progressive cognitive impairment or dementia prior to the current stroke. 2. Severe aphasia based on the National Institutes of Health Stroke Scale (NIHSS). 3. Uncontrolled Diabetes Mellitus (DM) with capillary blood glucose persistently more than 10 mmol/L 72 hours after stroke onset. 4. Severe stroke, comatoseness, or any condition precludes patients from answering the MoCA test.

Design outcomes

Primary

MeasureTime frame
Cognitive function before intervention and at three month after end of intervention Montreal Cognitive Assessment Test

Secondary

MeasureTime frame
Blood biomarkers serum samples collected from before intervention and at three month after end of intervention Enzyme-linked immunosorbent assay (ELISA)

Countries

Malaysia

Contacts

Public ContactSabarisah Hashim

Universiti Sains Malaysia

risha@usm.my609766347

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026